Journal of Nutrition 143, no. 1 (January 2013): 74–79.
263 G. Stix, “Got (skim) milk?: maybe a recipe for obesity and cancer.” Talking Back (blog), Scientific American, July 3, 2013.
264 X. Song et al., “Advanced glycation in D-galactose induced mouse aging model.” Mechanisms of Ageing and Development 108, no. 3 (May 1999): 239–51.
265 X. Cui et al., “Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-α-lipoic acid” Journal of Neuroscience Research 83, no. 8 (June 2006): 1584–90.
266 X. Cui et al., “D-Galactose-caused life shortening in Drosophila melanogaster and Musca domesticais associated with oxidative stress.” Biogerontology 5, no. 5 (October 2004): 317–26.
267 K. Michaëlsson et al., “Milk intake and risk of mortality and fractures in women and men: cohort studies.” BMJ (Clinical Research Ed.) 349 (January 2014): g6015.
268 J. M. Chan et al., “Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study.” American Journal of Clinical Nutrition 74, no. 4 (October 2001): 549–54.
269 L.-Q. Qin et al., “Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review.” International Journal of Food Sciences and Nutrition 60 Suppl 7 (January 2009): 330–40.
270 M. Park et al., “Consumption of milk and calcium in midlife and the future risk of Parkinson disease.” Neurology 64, no. 6 (March 2005): 1047–51.
271 C. Rodriguez et al., “Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.” Cancer Epidemiology Biomarkers and Prevention 12, no. 7 (July 2003): 597–603.
272 H. A. Bischoff-Ferrari et al., “Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies.” Journal of Bone and Mineral Research 26, no. 4 (April 2011): 833–39.
273 J. J. B. Anderson et al., “Calcium intake from diet and supplements and the risk of coronary artery calcification and its progression among older adults: 10-year follow-up of the multi-ethnic study of atherosclerosis (MESA).” Journal of the American Heart Association 5, no. 10 (October 2016): e003815.
274 K. Verburgh, “Nutrigerontology: why we need a new scientific discipline to develop diets and guidelines to reduce the risk of aging-related diseases.” Aging Cell (December 2014).
275 B. Vellas et al., “Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.” Current Alzheimer Research 6, no. 2 (April 2009): 144–51.
276 M. Asif et al., “An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.” Proceedings of the National Academy of Sciences of the United States of America 97, no. 6 (March 2000): 2809–13.
277 P. V Vaitkevicius et al., “A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.” Proceedings of the National Academy of Sciences of the United States of America 98, no. 3 (January 2001): 1171–75.
278 D. A. Kass et al., “Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.” Circulation 104, no. 13 (September 2001): 1464–70.
279 W. C. Little et al., “The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.” Journal of Cardiac Failure 11, no. 3 (April 2005): 191–95.
280 P. M. Keeney et al., “Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson’s disease cell model.” Human Gene Therapy 20, no. 8 (August 2009): 897–907.
281 S. Ellouze et al., “Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction.” American Journal of Human Genetics 83, no. 3 (September 2008): 373–87.
282 R. R. Thomas et al., “RhTFAM treatment stimulates mitochondrial oxidative metabolism and improves memory in aged mice.” Aging 4, no. 9 (September 2012): 620–35.
283 T.-Y. Lu et al., “Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells.” Nature Communications 4 (January 2013): 2307.
284 I. M. Conboy et al., “Rejuvenation of aged progenitor cells by exposure to a young systemic environment.” Nature 433, no. 7027 (February 2005): 760–64.
285 S. A. Villeda et al., “Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.” Nature Medicine 20, no. 6 (June 2014): 659–63.
286 A. Ocampo et al., “In vivo amelioration of age-associated hallmarks by partial reprogramming.” Cell 167, no. 7 (December 2016): 1719–33 e12.
287 A. Akesson et al., “Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study.” Journal of the American College of Cardiology 64, no. 13 (September 2014): 1299–306.
288 E. S. Ford et al., “Healthy living is the best revenge: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam study.” Archives of Internal Medicine 169, no. 15 (August 2009): 1355–62.
289 E. S. Ford et al., “Low-risk lifestyle behaviors and all-cause mortality: findings from the National Health and Nutrition Examination Survey III Mortality Study.” American Journal of Public Health 101, no. 10 (October 2011): 1922–29.
290 S. Yusuf et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.” Lancet 364, no. 9438 (January): 937–52.
291 S. E. Chiuve et al., “Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women.” JAMA 306, no. 1 (July 2011): 62–69.
292 A. M. Herskind et al., “The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870–1900.” Human Genetics 97, no. 3 (March 1996): 319–23.
293 S. Moalem, Het nut van ziekte (De Bezige Bij, 2007).
294 N. Barzilai et al., “The rationale for delaying aging and the prevention of age-related diseases.” Rambam Maimonides Medical Journal 3, no. 4 (October 2012): e0020.
295 L. A. Gavrilov et al., “Demographic consequences of defeating aging.” Rejuvenation Research 13, no. 2–3 (January): 329–34.
296 T. Parker-Pope, “For a healthy retirement, keep working.” The New York Times, October 19, 2009.
297 “Health and retirement study.” University of Michigan, hrsonline.isr.umich.edu.
298 C. Dufouil et al., “Older age at retirement is associated with decreased risk of dementia.” European Journal of Epidemiology 29, no. 5 (May 2014): 353–61.
299 M. C. Carlson et al., “Evidence for neurocognitive plasticity in at-risk older adults: the experience corps program.” Journals of Gerontology Series A, Biological Sciences and Medical Sciences 64, no. 12 (December 2009): 1275–82.
Об авторе
Крис Вербург, доктор медицины, – ученый из Центра междисциплинарных исследований имени Лео Апостела в Свободном университете Брюсселя; также он входит в преподавательский состав университета «Сингулярность», мозгового треста Кремниевой долины, который изучает возможности применения новых разрабатываемых технологий в борьбе с самыми сложными проблемами мира. Доктор Вербург работает над медицинскими процедурами, которые помогут увеличить продолжительность здоровой жизни и бороться с возрастными болезнями с помощью питания и самых современных биотехнологий. Он основал новую научную дисциплину, нутригеронтологию, изучающую диеты и правила, которые помогут замедлить старение и уменьшить риск возрастных заболеваний. Доктора Вербурга часто приглашают выступать с лекциями о новых разработках и сдвигах парадигм в медицине, здравоохранении, науках о старении и т. д.